Evidence map›Paper›PMID 35906658›Full record

ArticleReproductive biology and endocrinology : RB&E2022

Oxygen regulates ILC3 antigen presentation potential and pregnancy-related hormone actions.

Rebekka Einenkel, Jens Ehrhardt, Marek Zygmunt, Damián Oscar Muzzio

Open access · goldAbstract read
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. In situ licensing of mesenchymal stem cell immunomodulatory function via BMP-2 induced developmental process.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Less is more! Low amount ofFrontiers in immunology · 2024
    Article
  6. Article
  7. Review
  8. ILC3: a case of conflicted identity.Frontiers in immunology · 2023
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rebekka EinenkelDepartment of Obstetrics and Gynecology, University Medicine Greifswald, Greifswald, Germany.
Jens EhrhardtDepartment of Obstetrics and Gynecology, University Medicine Greifswald, Greifswald, Germany.
Marek ZygmuntDepartment of Obstetrics and Gynecology, University Medicine Greifswald, Greifswald, Germany.
Damián Oscar MuzzioDepartment of Obstetrics and Gynecology, University Medicine Greifswald, Greifswald, Germany. damian.muzzio@med.uni-greifswald.de.
Universitätsmedizin Greifswald · DEUniversity Hospital Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early pregnancy is marked by placentation and embryogenesis, which take place under physiological low oxygen concentrations. This oxygen condition is crucial for many aspects of placentation, trophoblast function, vascularization and immune function. Recently, a new family of innate lymphoid cells has been found to be expressed at the fetomaternal interface. Among these, type 3 innate lymphoid cells (ILC3) are important antigen presenting cells in the context of MHC-II. The expression of MHC-II on ILC3s during pregnancy is reduced. We tested the hypothesis that low oxygen concentrations reduce the potential of ILC3s to present antigens promoting fetal tolerance.Using an in vitro approach, NCR

Indexed as

Antigen PresentationLymphocytesFemaleHormonesHumansImmunity, InnateOxygenPregnancyTransforming Growth Factor beta1HormonesOxygenTransforming Growth Factor beta1hCGInnate lymphoid cellsOxygenPlacentaPregnancyTGF-β1Tolerance

Identifiers

PMID35906658
PMCPMC9336067
OpenAlexW4288425296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.